4.7 Article

Hsa_circ_0003258 promotes prostate cancer metastasis by complexing with IGF2BP3 and sponging miR-653-5p

期刊

MOLECULAR CANCER
卷 21, 期 1, 页码 -

出版社

BMC
DOI: 10.1186/s12943-021-01480-x

关键词

Prostate cancer; EMT; Hsa_circ_0003258; MiR-653-5p; IGF2BP3

资金

  1. National Natural Science Foundation of China [81972394, 81872901]
  2. Guangdong Basic and Applied Basic Research Foundation [2020A1515010066, 2019A1515110033]
  3. China Postdoctoral Science Foundation [2019M662865]
  4. Distinguished Young Talents in Higher Education Foundation of Guangdong Province [2019KQNCX115]
  5. Achievement Cultivation and Clinical Transformation Application Cultivation projects of the First Affiliated Hospital of Guangzhou Medical University [ZH201908]
  6. Science and Technology Plan Project of Guangzhou [202102010150]

向作者/读者索取更多资源

Hsa_circ_0003258 is upregulated in prostate cancer and associated with tumor progression. It promotes cell migration and tumor metastasis, while knockdown of hsa_circ_0003258 has the opposite effect. Mechanistically, hsa_circ_0003258 functions by sponging miR-653-5p and increasing the expression of ARHGAP5. Additionally, hsa_circ_0003258 physically binds to IGF2BP3 and enhances HDAC4 mRNA stability, activating the ERK signaling pathway and triggering EMT programming.
Background More and more studies have shown that circular RNAs (circRNAs) play a critical regulatory role in many cancers. However, the potential molecular mechanism of circRNAs in prostate cancer (PCa) remains largely unknown. Methods Differentially expressed circRNAs were identified by RNA sequencing. The expression of hsa_circ_0003258 was evaluated using quantitative real-time PCR and RNA in situ hybridization. The impacts of hsa_circ_0003258 on the metastasis of PCa cells were investigated by a series of in vitro and in vivo assays. Lastly, the underlying mechanism of hsa_circ_0003258 was revealed by Western blot, biotin-labeled RNA pulldown, RNA immunoprecipitation, luciferase assays and rescue experiments. Results Increased expression of hsa_circ_0003258 was found in PCa tissues and was associated with advanced TNM stage and ISUP grade. Overexpression of hsa_circ_0003258 promoted PCa cell migration by inducing epithelial mesenchymal transformation (EMT) in vitro as well as tumor metastasis in vivo, while knockdown of hsa_circ_0003258 exerts the opposite effect. Mechanistically, hsa_circ_0003258 could elevate the expression of Rho GTPase activating protein 5 (ARHGAP5) via sponging miR-653-5p. In addition, hsa_circ_0003258 physically binds to insulin like growth factor 2 mRNA binding protein 3 (IGF2BP3) in the cytoplasm and enhanced HDAC4 mRNA stability, in which it activates ERK signalling pathway, then triggers EMT programming and finally accelerates the metastasis of PCa. Conclusions Upregulation of hsa_circ_0003258 drives tumor progression through both hsa_circ_0003258/miR-653-5p/ARHGAP5 axis and hsa_circ_0003258/IGF2BP3 /HDAC4 axis. Hsa_circ_0003258 may act as a promising biomarker for metastasis of PCa and an attractive target for PCa intervention.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Review Pharmacology & Pharmacy

Progress in the studies on the molecular mechanisms associated with multidrug resistance in cancers

Lei Zhang, Biwei Ye, Zhuo Chen, Zhe-Sheng Chen

Summary: Chemotherapy is an important method for treating cancer, but multi-drug resistance (MDR) is a major reason for its failure. Almost all anti-tumor drugs develop drug resistance over time, reducing their effectiveness in killing cancer cells. Chemoresistance can lead to rapid cancer recurrence and patient death.

ACTA PHARMACEUTICA SINICA B (2023)

Article Chemistry, Multidisciplinary

Discovery of Norbornene as a Novel Hydrophobic Tag Applied in Protein Degradation

Shaowen Xie, Feiyan Zhan, Jingjie Zhu, Yuan Sun, Huajian Zhu, Jie Liu, Jian Chen, Zheying Zhu, Dong-Hua Yang, Zhe-Sheng Chen, Hong Yao, Jinyi Xu, Shengtao Xu

Summary: Hydrophobic tagging (HyT) is a potential therapeutic strategy for targeted protein degradation (TPD). In this study, norbornene was discovered as an unprecedented hydrophobic tag and successfully used to degrade ALK fusion protein and EZH2. The most promising degrader, Hyt-9, showed effective reduction of ALK levels without compensatory upregulation of ALK in vitro and exhibited significant tumor inhibition effect in vivo with moderate oral bioavailability. The discovery of novel hydrophobic norbornene tags shows promise for the future development of TPD technology.

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2023)

Article Biochemistry & Molecular Biology

Discovery of novel danshensu derivatives bearing pyrazolone moiety as potential anti-ischemic stroke agents with antioxidant activity

Yi Li, Yunchun Luo, Jing Wang, Hao Shi, Jun Liao, Yan Wang, Zhesheng Chen, Liyan Xiong, Chuan Zhang, Tingfang Wang

Summary: Novel danshensu derivatives with dual antioxidant effects were synthesized for the treatment of ischemic stroke. Del03 exhibited the strongest dose-dependent neuroprotective activity in vitro, reduced oxidative stress and promoted Nrf2 translocation.

BIOORGANIC CHEMISTRY (2023)

Editorial Material Pharmacology & Pharmacy

Editorial: Novel biomarkers for anticancer therapy

Ting Wang, Zhe-Sheng Chen, Chen Shi, Liang Ouyang, Hongtao Xiao

FRONTIERS IN PHARMACOLOGY (2023)

Article Materials Science, Multidisciplinary

High-performance flexible broadband photodetectors enabled by 2D Ta2NiSe5 nanosheets

Tingting Guo, Zixu Sa, Pengfei Wei, Yuxuan Jian, Xiang Chen, Zhesheng Chen, Jose Avila, Pavel Dudin, Zai-xing Yang, Xiufeng Song, Fengjing Liu, Shengli Zhang

Summary: Flexible broadband optoelectronic devices have great potential in various applications such as wearable optoelectronic systems, health care, and bio-imaging systems. This study demonstrates a high-performance photodetector based on Ta2NiSe5 nanosheets, which exhibit adjustable bandgap and excellent optical and electrical properties. The photodetector shows broad photodetection capability in the visible-infrared spectrum and retains its performance after bending cycles, indicating the great potential of 2D Ta2NiSe5 semiconductor in future wearable IR optoelectronic devices.

2D MATERIALS (2023)

Article Chemistry, Multidisciplinary

The Single-Cell Landscape of Intratumoral Heterogeneity and The Immunosuppressive Microenvironment in Liver and Brain Metastases of Breast Cancer

Yutian Zou, Feng Ye, Yanan Kong, Xiaoqian Hu, Xinpei Deng, Jindong Xie, Cailu Song, Xueqi Ou, Song Wu, Linyu Wu, Yi Xie, Wenwen Tian, Yuhui Tang, Chau-Wei Wong, Zhe-Sheng Chen, Xinhua Xie, Hailin Tang

Summary: This study utilizes single-cell RNA sequencing to construct a high-resolution map of the tumor ecosystem in liver and brain metastases of breast cancer. The results show remarkable reprogramming of immunosuppressive cells in the metastatic ecosystem, as well as the negligible expression of PD-1 and PD-L1/2 in CD8+ T cells and cancer/immune/stromal cells. The interactions between LAG3-LGALS3 and TIGIT-NECTIN2 are found to play dominant roles in immune escape.

ADVANCED SCIENCE (2023)

Article Chemistry, Multidisciplinary

Stellettin B Sensitizes Glioblastoma to DNA-Damaging Treatments by Suppressing PI3K-Mediated Homologous Recombination Repair

Xin Peng, Shaolu Zhang, Yingying Wang, Zhicheng Zhou, Zixiang Yu, Zhenxing Zhong, Liang Zhang, Zhe-Sheng Chen, Francois X. Claret, Moshe Elkabets, Feng Wang, Fan Sun, Ran Wang, Han Liang, Hou-Wen Lin, Dexin Kong

Summary: The triterpene compound STELB enhances the sensitivity of GBM to DNA-damaging treatments by inhibiting the expression of HR factors and can penetrate the blood-brain barrier to exert anti-GBM effects.

ADVANCED SCIENCE (2023)

Review Pharmacology & Pharmacy

Advances in receptor chromatography for drug discovery and drug-receptor interaction studies

Jia Fu, Wei Qin, Lu-Qi Cao, Zhe-Sheng Chen, Hui-Ling Cao

Summary: This review summarizes the applications and immobilization methods of receptor chromatography, which is widely used for high-throughput separation and accurate drug screening. The review focuses on screening active compounds in natural products, as well as the design and application of receptor chromatography in drug-receptor interactions.

DRUG DISCOVERY TODAY (2023)

Review Pharmacology & Pharmacy

Sunitinib resistance in renal cell carcinoma: From molecular mechanisms to predictive biomarkers

Juan Jin, Yuhao Xie, Jin-Shi Zhang, Jing-Quan Wang, Shi-Jie Dai, Wen-fang He, Shou-Ye Li, Charles R. Ashby Jr, Zhe-Sheng Chen, Qiang He

Summary: Renal cell carcinoma (RCC) is the most prevalent type of kidney cancer, and targeted therapy with Sunitinib has become the main treatment option due to the lack of efficacy in radiation therapy and chemotherapy. However, many patients develop resistance to Sunitinib within months of therapy. In this review, we discuss the molecular mechanisms of Sunitinib resistance, strategies to overcome it, and potential predictive biomarkers.

DRUG RESISTANCE UPDATES (2023)

Review Pharmacology & Pharmacy

Antimicrobial peptides for combating drug-resistant bacterial infections

Jiaqi Xuan, Weiguo Feng, Jiaye Wang, Ruichen Wang, Bowen Zhang, Letao Bo, Zhe-Sheng Chen, Hui Yang, Leming Sun

Summary: The long-term use of antibiotics leading to drug resistance has become a major concern. As the problem worsens, infections caused by multiple bacteria are increasing rapidly and posing serious threats to human health. Antimicrobial peptides (AMPs) offer a promising alternative to traditional antibiotics as they exhibit strong antimicrobial activity and unique mechanisms against drug-resistant bacterial infections. Current research on AMPs focuses on integrating new technologies, such as modifying the amino acid structure and exploring different delivery methods. This article provides valuable insights into the properties, mechanisms, and advancements of AMPs in combating drug-resistant bacterial infections.

DRUG RESISTANCE UPDATES (2023)

Article Chemistry, Medicinal

Discovery of a Novel, Potent, Orally Active, and Safe Inhibitor Targeting Human Mitochondrial RNA Polymerase

Xinnan Li, Xiaotong Ze, Shengnan Zhou, Zhaoxin Hu, Chen He, Yilin Jia, Lihua Liu, Tao Wang, Junda Li, Shengtao Xu, Dong-Hua Yang, Zhe-Sheng Chen, Hequan Yao, Jinyi Xu, Hong Yao

Summary: A novel compound D26, identified through the exploration and optimization of the first-in-class POLRMT inhibitor IMT1B, exhibits a strong antiproliferative effect on cancer cells and decreases mitochondrial-related gene expression. Mechanism studies revealed that D26 arrests the cell cycle at the G1 phase without affecting apoptosis, mitochondrial depolarization, or reactive oxidative stress generation. In vivo studies further demonstrated that D26 has more potent anticancer activity than the lead compound IMT1B, and no toxicity was observed.

JOURNAL OF MEDICINAL CHEMISTRY (2023)

Article Chemistry, Multidisciplinary

MYH10 Combines with MYH9 to Recruit USP45 by Deubiquitinating Snail and Promotes Serous Ovarian Cancer Carcinogenesis, Progression, and Cisplatin Resistance

Longyang Liu, Chunlin Chen, Ping Liu, Jing Li, Zhanjun Pang, Jiayu Zhu, Zhongqiu Lin, Haixu Zhou, Yingying Xie, Tiancai Lan, Zhe-Sheng Chen, Zhaoyang Zeng, Weiyi Fang

Summary: In this study, the expression and function of MYH10 in serous ovarian cancer (SOC) were investigated. It was found that MYH10 is associated with the invasive capacity and cisplatin resistance of SOC cells. Further experiments revealed that MYH10 interacts with MYH9 to promote tumorigenesis, progression, and cisplatin resistance in SOC. Clinical samples also showed elevated expression of MYH10 in SOC samples, which correlated positively with MYH9 expression. Co-expression of MYH10+/MYH9+ was identified as an independent prognostic factor for SOC patient survival.

ADVANCED SCIENCE (2023)

Editorial Material Immunology

Editorial: Role of gut microbiota in diabetes mellitus and tumor immunity

Jingxian Chen, Zhesheng Chen, Barkat Ali Khan, Kaijian Hou

FRONTIERS IN IMMUNOLOGY (2023)

Review Oncology

The Battlefield of Chemotherapy in Pediatric Cancers

Letao Bo, Youyou Wang, Yidong Li, John N. D. Wurpel, Zoufang Huang, Zhe-Sheng Chen

Summary: The survival rate for pediatric cancers has significantly improved in recent years. Conventional chemotherapy is crucial, especially in low- and middle-income countries with limited access to advanced treatments. Despite the expanded FDA approval of chemotherapy drugs for children, patients still face side effects and multidrug resistance remains a major challenge. This review focuses on the severe side effects of pediatric chemotherapy, mechanisms of multidrug resistance, and potential therapeutic options offered by drug transporters in pediatric tumors.

CANCERS (2023)

Article Oncology

SETD4 inhibits prostate cancer development by promoting H3K27me3-mediated NUPR1 transcriptional repression and cell cycle arrest

Chong Wang, Tao Wang, Kang-Jing Li, Ling-Hong Hu, Yue Li, Yu-Zhong Yu, Tao Xie, Sha Zhu, Du-Jiang Fu, Yang Wang, Xian-Zi Zeng, Feng-Ping Liu, Hong Chen, Zhe-Sheng Chen, Ning-Han Feng, Jinghua Liu, Yong Jiang, Shan-Chao Zhao

Summary: The SETD4 protein plays a crucial role in prostate cancer by catalyzing histone lysine methylation and suppressing NUPR1 transcription, leading to the inhibition of Akt signaling pathway and preventing PCa development.

CANCER LETTERS (2023)

暂无数据